Loading clinical trials...
Loading clinical trials...
The objective of this study is to prospectively observe clinical and economic outcomes with the use of SERI® in direct-to-implant breast reconstruction.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Sofregen Medical, Inc.
NCT07222514 · DIEP Flap Breast Reconstruction
NCT07209436 · Breast Reconstruction
NCT06556654 · Breast Reconstruction Surgery
NCT04891510 · Mastectomy, Mammaplasty, and more
NCT05363189 · Breast Reconstruction, Breast Cancer
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions